|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/22 | |
| A61K 9/24 | |||
| A61K 31/485 | |||
| A61P 25/04 |
| (11) | Patento numeris | 2402005 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11178912.9 |
| Europos patento paraiškos padavimo data | 2006-08-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-01-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 772466 P | 2006-02-10 | US | |
| 710772 P | 2005-08-24 | US |
| (72) |
BAICHWAL, Anand, US
SCIASCIA, Thomas, US
DIEHL, Donald, US
VOGLER, Brian, US
|
| (73) |
Endo Pharmaceuticals Inc.,
1400 Atwater Drive, Malvem PA 19355,
US
|
| (54) | Sustained release formulations of nalbuphine |
| Sustained release formulations of nalbuphine |